IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q3 2020 Holdings

Filed 2020-11-23 | 5 holdings | $120.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$59.9K3,766,66649.9%
Cara Therapeutics Inc(CARAEUR)COM140755109$35.6K2,799,05829.7%
Mersana Therapeutics IncCOM59045L106$14.8K796,45812.3%
Livexlive Media IncCOM NEW53839L208$9.7K3,724,1388.0%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$62159,6010.1%